Despite market volatility, the biotech industry has performed relatively well due to breakthrough advances, advancement in agriculture biotechnology and inelastic demand for healthcare products and services. Investors looking to invest in biotech stocks could consider buying LAVA Therapeutics N.V. (LVTX) now.
However, considering the lingering macroeconomic headwinds, I think it is best to steer clear of fundamentally weak Talaris Therapeutics, Inc. (TALS).
